semaglutide immunoassay fda cleared detection assay Multifactor Quality and Safety Analysis of Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study Obesity, Diabetes and Metabolic Disease

So here are some takeaways on the longevity of the obesity platform: Even without GLP-1 craze they grew the business (profitably?) to a $100M run-rate in 7 months with oral weight loss medications alone We will see a flood of new GLP-1 medications enter the market and the situation will move quickly and be fluid including the introduction of oral compounds that may lead to other use-cases for Hims There is some sort of precedent that compounding certain elements like end-dosage or side effect mitigation is considered clinically necessary and therefore defensible Hims & Hers will also offer brand-name GLP-1s on platform, maybe alluding to expectations of reduction in out of pocket cost over time, or an increase in supply My unsolicited thoughts for Hims would be to take advantage of this huge surge in cash and invest it into the sustainable, growing parts of the business

Strength train

Animal studies show significant improvements in body composition, metabolic markers, and muscle function with minimal adverse effects

Rehabilitation and Lifestyle Changes Physical therapy (PT) is essential in Rheumatoid Arthritis treatment as it helps maintain or increase function, strength, and mobility in affected joints